projectdream
.io
Search
Home
About Us
Research Area
PI3K Inhibitors
7
Apoptosis related Inhibitors
6
Autophagy Modulators
6
PKC Inhibitors
5
mTOR Inhibitors
3
Synthetic Lethality Inhibitors
3
PERK Inhibitors
2
P-gp Inhibitors
2
Endogenous Metabolite Inhibitors
2
p53 Inhibitors & Activators
2
PDGFR Inhibitors
2
NF-κB Inhibitors
2
PARP Inhibitors
2
IFN Inhibitors
1
CDK Inhibitors
1
HIV Inhibitors
1
Phospholipase Inhibitors
1
c-Kit Inhibitors
1
CPT Inhibitors
1
Histone Acetyltransferase Inhibitors
1
NADPH-oxidase Inhibitors
1
UGT Inhibitors
1
Interleukins Inhibitors
1
PIKfyve Inhibitors
1
VEGFR Inhibitors
1
ROS Inhibitors
1
phosphatase Inhibitors
1
DNA/RNA Synthesis Inhibitors
1
JAK Inhibitors
1
FLT3 Inhibitors
1
ATM/ATR Inhibitors
1
PLK Inhibitors
1
Archives
2026-10
34
Author
Contact Us
Resources
Phospholipase Inhibitors
AACOCF3 Selectively Inhibits Cytosolic Phospholipase A2 to Block Inflammatory Eicosanoid Biosynthesis
PI3K Inhibitors
7
Apoptosis related Inhibitors
6
Autophagy Modulators
6
PKC Inhibitors
5
mTOR Inhibitors
3
Synthetic Lethality Inhibitors
3
PERK Inhibitors
2
P-gp Inhibitors
2
Endogenous Metabolite Inhibitors
2
p53 Inhibitors & Activators
2
PDGFR Inhibitors
2
NF-κB Inhibitors
2
PARP Inhibitors
2
IFN Inhibitors
1
CDK Inhibitors
1
HIV Inhibitors
1
Phospholipase Inhibitors
1
c-Kit Inhibitors
1
CPT Inhibitors
1
Histone Acetyltransferase Inhibitors
1
NADPH-oxidase Inhibitors
1
UGT Inhibitors
1
Interleukins Inhibitors
1
PIKfyve Inhibitors
1
VEGFR Inhibitors
1
ROS Inhibitors
1
phosphatase Inhibitors
1
DNA/RNA Synthesis Inhibitors
1
JAK Inhibitors
1
FLT3 Inhibitors
1
ATM/ATR Inhibitors
1
PLK Inhibitors
1
